Bluesky Facebook Reddit Email

The nuclear phosphoinositide-p53 signalosome in the regulation of cell motility

08.08.25 | Higher Education Press

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.


In this review, the authors present recent findings that uncover a previously unappreciated nuclear signaling hub: the PIPn-p53 signalosome. This complex not only modulates AKT activation within the nucleus but also integrates two major oncogenic pathways—p53 dysregulation and PI3K-AKT amplification—into a unified mechanism driving cancer cell migration and invasion.

Key points of the review include:

This review highlights the nuclear PIPn-p53 signalosome as a central regulator of cancer cell motility and a promising target for metastasis therapy. The work entitled “The Nuclear Phosphoinositide-p53 Signalosome in the Regulation of Cell Motility” was published in Protein & Cell (Advance access May 26, 2025).

Protein & Cell

10.1093/procel/pwaf043

Systematic review

Not applicable

The nuclear phosphoinositide-p53 signalosome in the regulation of cell motility

26-May-2025

Keywords

Article Information

Contact Information

Rong Xie
Higher Education Press
xierong@hep.com.cn

Source

How to Cite This Article

APA:
Higher Education Press. (2025, August 8). The nuclear phosphoinositide-p53 signalosome in the regulation of cell motility. Brightsurf News. https://www.brightsurf.com/news/19NK4R01/the-nuclear-phosphoinositide-p53-signalosome-in-the-regulation-of-cell-motility.html
MLA:
"The nuclear phosphoinositide-p53 signalosome in the regulation of cell motility." Brightsurf News, Aug. 8 2025, https://www.brightsurf.com/news/19NK4R01/the-nuclear-phosphoinositide-p53-signalosome-in-the-regulation-of-cell-motility.html.